Abstract
Purpose
A low dose of morphine, given intrathecally is an effective postoperative analgesic technique and is widely used in cesarean section. Delayed respiratory depression is the most feared side effect of this technique. However, this side effect has not been thoroughly reported in the obstetric population. The aim of this study was to describe respiratory depression associated with intrathecal morphine in postcesarean women, and to estimate its incidence.
Methods
We retrospectively reviewed the obstetric anesthesia database at our institution from April 2000 to December 2006. Patients who were given 0.15 mg intrathecal morphine for cesarean section were identified. From this group, we identified patients who developed bradypnea (respiratory rate ≤ 10 breaths·min−1) within 24 h after the intrathecal injection.
Results
Of 1915 women given 0.15 mg intrathecal morphine for postcesarean analgesia, 6 patients exhibited bradypnea within 24 h after the injection of morphine. Four of these 6 patients developed mild respiratory depression, which was treated with supplemental oxygen and/or encouragement of breathing. One patient had severe respiratory depression, and repeated episodes of oxygen desaturation below 90% and 30-s apneas were noted. Naloxone was required for this patient. One woman had obstructive sleep apnea which was not associated with the intrathecal morphine.
Conclusion
Of 1915 patients, 5 women (0.26%) developed bradypnea associated with 0.15 mg intrathecal morphine. The incidence of severe bradypnea requiring naloxone was 1/1915 (0.052%).
Similar content being viewed by others
References
Dahl JB, Jeppesen IS, Jorgensen H, Wetterslev J, Moiniche S. Intraoperative and postoperative analgesic efficacy and adverse effects of intrathecal opioids in patients undergoing cesarean section with spinal anesthesia: a qualitative and quantitative systematic review of randomized controlled trials. Anesthesiology. 1999;91:1919–1927.
Hughes SC, Levinson G, Rosen MA. Anesthesia for cesarean section. In: Hughes SC, Levinson G, Rosen MA, editors. Anesthesia for obstetrics. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001; p. 201–236.
Ayoub CM, Sinatra RS. Postoperative analgesia: epidural and spinal techniques. In: Chestnut DH, editor. Obstetric anesthesia. 3rd ed. Philadelphia: Elsevier Mosby; 2004; p. 472–503.
Swart M, Sewell J, Thomas D. Intrathecal morphine for caesarean section: an assessment of pain relief, satisfaction and side-effects. Anaesthesia. 1997;52:373–377.
Duale C, Frey C, Bolandard F, Barriere A, Schoeffler P. Epidural versus intrathecal morphine for postoperative analgesia after Caesarean section. Br J Anaesth. 2003;91:690–694.
Abouleish E, Rawal N, Rashad MN. The addition of 0.2 mg subarachnoid morphine to hyperbaric bupivacaine for cesarean delivery: a prospective study of 856 cases. Reg Anesth. 1991;16:137–140.
Gjessing J, Tomlin PJ. Postoperative pain control with intrathecal morphine. Anaesthesia. 1981;36:268–276.
Glass PS. Respiratory depression following only 0.4 mg of intrathecal morphine. Anesthesiology. 1984;60:256–257.
Neustein SM, Cottone TM. Prolonged respiratory depression after intrathecal morphine. J Cardiothorac Vasc Anesth. 2003;17:230–231.
Rawal N, Arner S, Gustafsson LL, Allvin R. Present state of extradural and intrathecal opioid analgesia in Sweden. A nationwide follow-up survey. Br J Anaesth. 1987;59:791–799.
Rawal N, Allvin R. Epidural and intrathecal opioids for postoperative pain management in Europe—a 17-nation questionnaire study of selected hospitals. Euro Pain Study Group on Acute Pain. Acta Anaesthesiol Scand. 1996;40:1119–1126.
Gwirtz KH, Young JV, Byers RS, Alley C, Levin K, Walker SG, Stoelting RK. The safety and efficacy of intrathecal opioid analgesia for acute postoperative pain: 7 years’ experience with 5969 surgical patients at Indiana University Hospital. Anesth Analg. 1999;88:599–604.
Shapiro A, Zohar E, Zaslansky R, Hoppenstein D, Shabat S, Fredman B. The frequency and timing of respiratory depression in 1524 postoperative patients treated with systemic or neuraxial morphine. J Clin Anesth. 2005;17:537–542.
Chaney MA. Side effects of intrathecal and epidural opioids. Can J Anaesth. 1995;42:891–903.
Saaresranta T, Polo O. Hormones and breathing. Chest. 2002;122:2165–2182.
Bailey PL, Lu JK, Pace NL, Orr JA, White JL, Hamber EA, Slawson MH, Crouch DJ, Rollins DE. Effects of intrathecal morphine on the ventilatory response to hypoxia. N Engl J Med. 2000;343:1228–1234.
Bailey PL, Rhondeau S, Schafer PG, Lu JK, Timmins BS, Foster W, Pace NL, Stanley TH. Dose-response pharmacology of intrathecal morphine in human volunteers. Anesthesiology. 1993;79:49–59.
Ko S, Goldstein DH, VanDenKerkhof EG. Definitions of “respiratory depression” with intrathecal morphine postoperative analgesia: a review of the literature. Can J Anaesth. 2003;50:679–688.
Author information
Authors and Affiliations
About this article
Cite this article
Kato, R., Shimamoto, H., Terui, K. et al. Delayed respiratory depression associated with 0.15 mg intrathecal morphine for cesarean section: a review of 1915 cases. J Anesth 22, 112–116 (2008). https://doi.org/10.1007/s00540-007-0593-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-007-0593-z